India vaccination centres close due to shortages amid another record COVID-19 surge

Click to play video: 'COVID-19 patients in India can’t find hospital beds'
COVID-19 patients in India can’t find hospital beds
WATCH: COVID-19 patients in India can't find hospital beds – Apr 29, 2021

All vaccination centers in India’s financial capital of Mumbai were shut for three days starting Friday due to a shortage of vaccines, said authorities, as the country posted another record daily rise in coronavirus cases.

India reported 386,452 news cases on Friday, while deaths from COVID-19 jumped by 3,498 over the last 24 hours, according to health ministry data.

However, medical experts believe actual COVID-19 numbers in the world’s second-most populous nation may be five to 10 times greater than the official tally.

India has added about 7.7 million cases since the end of February, when its second wave picked up steam, according to a Reuters tally. In contrast, it took India nearly six months to add the previous 7.7 million cases.

Story continues below advertisement

The country is in deep crisis, with hospitals and morgues overwhelmed, medicines and oxygen in short supply and strict curbs on movement in its biggest cities.

India is the world’s biggest producer of vaccines but does not have enough stockpiles to keep up with the second deadly COVID-19 wave, despite Prime Minister Narendra Modi’s government planning to vaccinate all adults starting May 1. Only about 9% of India’s 1.4 billion people have received a vaccine dose since January.

Several states have said they will be unable to immunize people aged 18-45 immediately.

Click to play video: '‘Complacency’ responsible for COVID-19 crisis in India, says doctor'
‘Complacency’ responsible for COVID-19 crisis in India, says doctor

Modi is scheduled to meet cabinet of ministers on Friday as the wave of infections cripples the nation’s health system and threatens to impact major businesses as absenteeism grows with staff falling sick or taking leave to tend to sick relatives.

Story continues below advertisement

World aid has started arriving in India as it struggles to combat what has been described as a humanitarian disaster.

The latest health and medical news emailed to you every Sunday.

The first U.S. flight carrying oxygen cylinders, regulators, rapid diagnostic kits, N95 masks and pulse oximeters arrived in the Indian capital Delhi on Friday.

“Just as India came to our aid early in the pandemic, the U.S. is committed to working urgently to provide assistance to India in its time of need,” U.S. Secretary of State Antony Blinken said on Twitter.

“Today we are proud to deliver our first shipment of critical oxygen equipment, therapeutics and raw materials for vaccine production.”

Story continues below advertisement

Oxygen crisis expected until mid-May

The United States will send more than $100 million in medical aid, including 1,000 oxygen cylinders, 15 million N95 masks and 1 million rapid diagnostic tests. It also has redirected its own order of AstraZeneca supplies to India, to allow it to make more than 20 million doses.

Shipments from other countries continued to pour in, with a third one from the United Kingdom reaching earlier in the day. Romania and Ireland also sent supplies late on Thursday.

India’s severe medical oxygen supply crisis is expected to ease by mid-May, a top industry executive told Reuters, with output rising by 25% and transport infrastructure ready to cope with a surge in demand.

A worker died and at least two were injured after an oxygen cylinder exploded during refilling at Panki Oxygen refilling plant in Kanpur in India’s northern state of Uttar Pradesh earlier on Friday, local police told Reuters.

The incident comes a week after at least 22 patients died at a public hospital in India’s western Maharashtra state when their oxygen supply ran out after a leak in the tank.

India will receive a first batch of Russia’s Sputnik V vaccine on May 1. Russia’s RDIF sovereign wealth fund, which markets Sputnik V globally, has signed deals with five Indian manufacturers for more than 850 million vaccine doses a year.

Story continues below advertisement

Prominent U.S. disease modeler Chris Murray, from the University of Washington, said the sheer magnitude of infections in India in a short period of time suggests an “escape variant” may be overpowering any prior immunity from natural infections in those populations.

Click to play video: 'India’s COVID-19 crisis: Doctor recalls famous play ‘An Enemy of the People’ to describe present situation'
India’s COVID-19 crisis: Doctor recalls famous play ‘An Enemy of the People’ to describe present situation

“That makes it most likely that it’s B.1.617,” he said. But Murray cautioned that gene sequencing data on the coronavirus in India is sparse, and that many cases are also being driven by the UK and South African variants.

Carlo Federico Perno, Head of Microbiology and Immunology Diagnostics at Rome’s Bambino Gesù Hospital, said the Indian variant couldn’t alone be the reason for India’s huge surge, pointing instead to large social gatherings.

Modi has been criticized for allowing massive political rallies and religious festivals which have been super-spreader events in recent weeks.

Story continues below advertisement

(Reporting by Anuron Kumar Mitra in Bengaluru; Sanjeev Miglani and Tanvi Mehta in Delhi, Shilpa Jamkhandikar in Mumbai; Writing by Michael Perry, Editing by Christian Schmollinger and Raju Gopalakrishnan)

Sponsored content